CORRECTION: Wedbush Maintains Neutral On Vera Therapeutics, Raises Price Target To $43

Benzinga Newsdesk www.benzinga.com Positive 51.3%

Neg 0% Neu 0% Pos 51.3%

Wedbush analyst Laura Chico maintains Vera Therapeutics (NASDAQ:VERA) with a Neutral and raises the price target from $35 to $43.